| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |